Projects per year
Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 13 Similar Profiles
Ovarian Neoplasms
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Endometrial Neoplasms
Medicine & Life Sciences
Carcinoma
Medicine & Life Sciences
Drug Therapy
Medicine & Life Sciences
Carboplatin
Medicine & Life Sciences
Survival
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 1991 2017
- 12 Finished
Glycoengineered MSCs for Targeting Platinum Resistant Ov
Prabha, S., Argenta, P. A. & Ramakrishnan, S.
7/1/16 → 12/31/17
Project: Research project
Platinum
Neoplasms
Women's Cancer Center Protocol #63
REALIEF NEUORPATHY CENTERS OF MN, P.A.
9/1/13 → 4/15/16
Project: Research project
Peripheral Nervous System Diseases
Double-Blind Method
Drug Therapy
Neoplasms
Therapeutics
Pilot Study of Hyperthermic Intraperitoneal Chemotherapy
Argenta, P. A. & Judson, P.
9/7/10 → 8/31/12
Project: Research project
Carboplatin
Ovarian Neoplasms
Recurrence
Endometrial Neoplasms
Estrogen Receptors
Drug Therapy
irosustat
Endometrial Neoplasms
Estrogen Receptors
Drug Therapy
irosustat
Research Output 1994 2019
A patient-centered mobile health application to motivate use of genetic counseling among women with ovarian cancer: A pilot randomized controlled trial
Vogel, R. I., Niendorf, K. B., Petzel, S., Lee, H., Teoh, D. G., Blaes, A. H., Argenta, P. A., Rivard, C., Winterhoff, B. J., Lee, H. Y. & Geller, M. A., Apr 1 2019, In : Gynecologic oncology. 153, 1, p. 100-107 8 p.Research output: Contribution to journal › Article
Mobile Applications
Telemedicine
Genetic Counseling
Ovarian Neoplasms
Randomized Controlled Trials
Biological insights into chemotherapy resistance in ovarian cancer
Glasgow, M. A., Argenta, P., Abrahante, J. E., Shetty, M., Talukdar, S., Croonquist, P. A., Khalifa, M. A. & Starr, T. K., May 1 2019, In : International journal of molecular sciences. 20, 9, 2131.Research output: Contribution to journal › Article
Open Access
Chemotherapy
chemotherapy
Ovarian Neoplasms
cancer
Drug Therapy
4
Citations
(Scopus)
Predictive modeling for determination of microscopic residual disease at primary cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 Study
Horowitz, N. S., Larry Maxwell, G., Miller, A., Hamilton, C. A., Rungruang, B., Rodriguez, N., Richard, S. D., Krivak, T. C., Fowler, J. M., Mutch, D. G., Van Le, L., Lee, R. B., Argenta, P., Bender, D., Tewari, K. S., Gershenson, D., Java, J. J. & Bookman, M. A., Jan 1 2018, In : Gynecologic oncology. 148, 1, p. 49-55 7 p.Research output: Contribution to journal › Article
Area Under Curve
Molecular Imaging
Cytomegalovirus Infections
Ascites
ROC Curve
1
Citation
(Scopus)
RNA Sequencing of Carboplatin- and Paclitaxel-Resistant Endometrial Cancer Cells Reveals New Stratification Markers and Molecular Targets for Cancer Treatment
Hellweg, R., Mooneyham, A., Chang, Z., Shetty, M., Emmings, E., Iizuka, Y., Clark, C., Starr, T., Abrahante - Llorens, J. E., Schütz, F., Konecny, G., Argenta, P. A. & Bazzaro, M., Oct 1 2018, In : Hormones and Cancer. 9, 5, p. 326-337 12 p.Research output: Contribution to journal › Article
RNA Sequence Analysis
Carboplatin
Endometrial Neoplasms
Paclitaxel
Neoplasms
4
Citations
(Scopus)
An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience
Oliver, K. E., Brady, W. E., Birrer, M., Gershenson, D. M., Fleming, G., Copeland, L. J., Tewari, K., Argenta, P. A., Mannel, R. S., Secord, A. A., Stephan, J. M., Mutch, D. G., Stehman, F. B., Muggia, F. M., Rose, P. G., Armstrong, D. K., Bookman, M. A., Burger, R. A. & Farley, J. H., Nov 1 2017, In : Gynecologic oncology. 147, 2, p. 243-249 7 p.Research output: Contribution to journal › Article
Platinum
Ovarian Neoplasms
Disease-Free Survival
Carcinoma
Survival